These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34730982)

  • 21. 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.
    Jia B; Shi J; Yang Z; Xu B; Liu Z; Zhao H; Liu S; Wang F
    Bioconjug Chem; 2006; 17(4):1069-76. PubMed ID: 16848417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel concept of radiosynthesis of a (99m)Tc-labeled dimeric RGD peptide as a potential radiotracer for tumor imaging.
    Mittal S; Bhadwal M; Chakraborty S; Sarma HD; Banerjee S; Pillai MR
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1808-12. PubMed ID: 23414841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
    Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
    Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
    Fu T; Qu W; Qiu F; Li Y; Shao G; Tian W; Hua Z; Zhang Y; Wang F
    Cancer Biother Radiopharm; 2014 Nov; 29(9):351-8. PubMed ID: 25286251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
    Shao G; Zhou Y; Wang F; Liu S
    Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
    Dearling JL; Barnes JW; Panigrahy D; Zimmerman RE; Fahey F; Treves ST; Morrison MS; Kieran MW; Packard AB
    Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging integrin α(v)β(3) positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake.
    Wu H; Chen H; Sun Y; Wan Y; Wang F; Jia B; Su X
    Cancer Lett; 2013 Jul; 335(1):75-80. PubMed ID: 23403076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural modification on the Lys linker enhanced tumor to kidney uptake ratios of 99mTc-labeled RGD-conjugated α-MSH hybrid peptides.
    Yang J; Lu J; Miao Y
    Mol Pharm; 2012 May; 9(5):1418-24. PubMed ID: 22452443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
    Ocampo-García BE; Santos-Cuevas CL; De León-Rodríguez LM; García-Becerra R; Ordaz-Rosado D; Luna-Guitiérrez MA; Jiménez-Mancilla NP; Romero-Piña ME; Ferro-Flores G
    Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of Integrin α
    Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
    Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and comparative in vivo evaluation of
    Vats K; Satpati D; Sharma R; Sarma HD; Banerjee S
    Chem Biol Drug Des; 2017 Mar; 89(3):371-378. PubMed ID: 27561428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Potential of (99m)Tc(CO)3-Labeled Triazolyl Peptides for Tumor Diagnosis.
    Gaonkar RH; Ganguly S; Baishya R; Dewanjee S; Sinha S; Gupta A; Ganguly S; Debnath MC
    Cancer Biother Radiopharm; 2016 Apr; 31(3):110-7. PubMed ID: 27093344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.
    Ji S; Zhou Y; Voorbach MJ; Shao G; Zhang Y; Fox GB; Albert DH; Luo Y; Liu S; Mudd SR
    J Pharmacol Exp Ther; 2013 Aug; 346(2):251-8. PubMed ID: 23750021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification-Free Method for Preparing Technetium-99m-Labeled Multivalent Probes for Enhanced in Vivo Imaging of Saturable Systems.
    Mizuno Y; Uehara T; Hanaoka H; Endo Y; Jen CW; Arano Y
    J Med Chem; 2016 Apr; 59(7):3331-9. PubMed ID: 26999587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
    Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression.
    Haubner R; Bruchertseifer F; Bock M; Kessler H; Schwaiger M; Wester HJ
    Nuklearmedizin; 2004 Feb; 43(1):26-32. PubMed ID: 14978538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
    Yang J; Hu CA; Miao Y
    Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
    Su ZF; Liu G; Gupta S; Zhu Z; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2002; 13(3):561-70. PubMed ID: 12009947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.